These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 32895041

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia.
    Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG.
    JAMA Pediatr; 2017 Dec 01; 171(12):1184-1191. PubMed ID: 29084336
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
    Ambroggio L, Taylor JA, Tabb LP, Newschaffer CJ, Evans AA, Shah SS.
    J Pediatr; 2012 Dec 01; 161(6):1097-103. PubMed ID: 22901738
    [Abstract] [Full Text] [Related]

  • 4. Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia.
    Ambroggio L, Test M, Metlay JP, Graf TR, Blosky MA, Macaluso M, Shah SS.
    Pediatr Pulmonol; 2016 May 01; 51(5):541-8. PubMed ID: 26367389
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
    Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M.
    Int J Antimicrob Agents; 2023 Sep 01; 62(3):106905. PubMed ID: 37385561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.
    Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.
    Chest; 2019 Apr 01; 155(4):795-804. PubMed ID: 30471269
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman IM.
    J Antimicrob Chemother; 2003 Oct 01; 52(4):555-63. PubMed ID: 12972448
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of the combination and quinolone therapy in community acquired pneumonia].
    Kılıç Soylar Ö, Kılınç O, Ellidokuz H.
    Tuberk Toraks; 2015 Sep 01; 63(3):165-9. PubMed ID: 26523897
    [Abstract] [Full Text] [Related]

  • 19. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
    Vardakas KZ, Trigkidis KK, Falagas ME.
    Clin Microbiol Infect; 2017 Apr 01; 23(4):234-241. PubMed ID: 27965070
    [Abstract] [Full Text] [Related]

  • 20. The science of selecting antimicrobials for community-acquired pneumonia (CAP).
    File TM.
    J Manag Care Pharm; 2009 Mar 01; 15(2 Suppl):S5-11. PubMed ID: 19236135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.